22-23882536-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001024939.4(SLC2A11):c.772G>A(p.Gly258Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000165 in 1,454,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024939.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A11 | NM_001024939.4 | c.772G>A | p.Gly258Ser | missense_variant | 7/12 | ENST00000316185.9 | NP_001020110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A11 | ENST00000316185.9 | c.772G>A | p.Gly258Ser | missense_variant | 7/12 | 1 | NM_001024939.4 | ENSP00000326748.8 | ||
ENSG00000251357 | ENST00000433835.3 | c.431+5365G>A | intron_variant | 5 | ENSP00000400325.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000603 AC: 14AN: 232258Hom.: 0 AF XY: 0.0000628 AC XY: 8AN XY: 127420
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1454342Hom.: 0 Cov.: 33 AF XY: 0.0000194 AC XY: 14AN XY: 723184
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.784G>A (p.G262S) alteration is located in exon 8 (coding exon 7) of the SLC2A11 gene. This alteration results from a G to A substitution at nucleotide position 784, causing the glycine (G) at amino acid position 262 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at